Eleanor de Groot
Chief Tech/Sci/R&D Officer at BRII BIOSCIENCES LIMITED
Eleanor de Groot active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BRII BIOSCIENCES LIMITED | Chief Tech/Sci/R&D Officer | 15/08/2022 | - |
Career history of Eleanor de Groot
Former positions of Eleanor de Groot
| Companies | Position | Start | End |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Operating Officer | 01/09/2021 | 01/05/2022 |
| Corporate Officer/Principal | 01/07/2015 | 01/09/2021 | |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Corporate Officer/Principal | 01/01/2009 | 01/07/2015 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Corporate Officer/Principal | - | - |
Shell Chemicals Ltd.
 Shell Chemicals Ltd. Chemicals: SpecialtyProcess Industries Shell Chemicals Ltd. manufactures basic organic and inorganic chemicals. Its products include alpha olefins, aromatics, corterra, ethylene oxide, lower olefins, solvents, and propylene oxide. The company was founded in 1929 and is headquartered in London, UK. | Corporate Officer/Principal | - | - |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 01/01/2002 | - |
Training of Eleanor de Groot
| Massachusetts Institute of Technology | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| Rice University | Masters Business Admin |
Statistics
International
| United States | 8 |
| United Kingdom | 2 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Private companies | 4 |
|---|---|
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Shell Chemicals Ltd.
Shell Chemicals Ltd. Chemicals: SpecialtyProcess Industries Shell Chemicals Ltd. manufactures basic organic and inorganic chemicals. Its products include alpha olefins, aromatics, corterra, ethylene oxide, lower olefins, solvents, and propylene oxide. The company was founded in 1929 and is headquartered in London, UK. | Process Industries |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
- Stock Market
- Insiders
- Eleanor de Groot
- Experience
